MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response

BACKGROUND: The DNA repair protein O(6)-methylguanine-DNA methyltransferase (MGMT) causes resistance of cancer cells to alkylating agents and, therefore, is a well-established predictive marker for high-grade gliomas that are routinely treated with alkylating drugs. Since MGMT is highly epigenetical...

Descripción completa

Detalles Bibliográficos
Autores principales: Switzeny, Olivier J., Christmann, Markus, Renovanz, Mirjam, Giese, Alf, Sommer, Clemens, Kaina, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858829/
https://www.ncbi.nlm.nih.gov/pubmed/27158275
http://dx.doi.org/10.1186/s13148-016-0204-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858829/
https://www.ncbi.nlm.nih.gov/pubmed/27158275
http://dx.doi.org/10.1186/s13148-016-0204-7

Ejemplares similares